Chediak-Higashi syndrome presenting as young-onset levodopa-responsive parkinsonism

Authors

  • Vikas Bhambhani MD,

    1. Human Biochemical Genetics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
    Search for more papers by this author
  • Wendy J. Introne MD,

    1. Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
    Search for more papers by this author
  • Codrin Lungu MD,

    1. Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA
    Search for more papers by this author
  • Andrew Cullinane PhD,

    1. Human Biochemical Genetics Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
    Search for more papers by this author
  • Camilo Toro MD

    Corresponding author
    1. Office of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA
    • Correspondence to: Camilo Toro, MD, Office of the Clinical Director, NHGRI, NIH, Bethesda, MD Medical Neurology Branch, National Human Genome Research Institute, National Institutes of Health, 10 Center Drive, Hatfiled 3-2551, Bethesda, MD 20892; toroc@mail.nih.gov

    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: This work was conducted through funding from the National Human Genome Research Institute Intramural Research Program.

  • Full financial disclosures and author roles may be found in the online version of this article.

No abstract is available for this article.

Ancillary